1. Comparison of Curettage Plus Platelet-Rich Plasma Gel and Curettage Plus Phenol Application in Treatment of Pilonidal Sinus Disease: A Randomized Trial
- Author
-
Barış Sevinç, Ömer Karahan, and Nurullah Damburacı
- Subjects
medicine.medical_specialty ,Pilonidal disease ,business.industry ,medicine.medical_treatment ,Gastroenterology ,Healing time ,General Medicine ,Curettage ,Surgery ,law.invention ,Clinical trial ,Full Protocol ,Randomized controlled trial ,law ,Platelet-rich plasma ,Sinus disease ,Medicine ,business - Abstract
BACKGROUND As a chronic condition, pilonidal disease affects a young population and the surgical procedures performed to treat this condition require a recovery time with time off work. Therefore, the search for ideal treatment is still ongoing. OBJECTIVE The aim of this study is to compare early and late results of two minimally invasive treatment options used to treat pilonidal disease. DESIGN This study is designed as a two parallel group randomized clinical trial. SETTINGS The study consists of two groups: curettage+platelet rich plasma and curettage+phenol. PATIENTS Patients with pilonidal disease were evaluated for the study, and enrolled if they met inclusion criteria and gave informed consent. INTERVENTIONS Patients in the platelet rich plasma group were treated using curettage+platelet rich plasma gel. In Phenol group patients were treated using curettage+crystallized phenol. MAIN OUTCOME MEASURES The primary study end point was the time to achieve healing; the secondary outcome was recurrence rate. RESULTS In the platelet rich plasma group, 96% of cases achieved healing after one application. In the phenol group, only 53% cases achieved healing after one application. The median healing time was shorter in the platelet rich plasma group; 6 (4-14) vs 10 (5-42) days (p
- Published
- 2022
- Full Text
- View/download PDF